References
- Ferrara F, Schiffer CA. Acute myeloid leukaemia in adults. Lancet 2013;381:484–495.
- Fischer K, Scholl C, Salat J, et al. Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia. Blood 1996;88:3962–3971.
- Mrozek K, Marcucci G, Paschka P, et al. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood 2007;109:431–448.
- Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012;62:220–241.
- Saltzman BS, Weiss NS, Sieh W, et al. Use of antihypertensive medications and breast cancer risk. Cancer Causes Control 2013;24: 365–371.
- Azoulay L, Assimes TL, Yin H, et al. Long-term use of angiotensin receptor blockers and the risk of cancer. PLoS One 2012;7:e50893.
- McMenamin UC, Murray LJ, Cantwell MM, et al. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review. Cancer Causes Control 2012;23:221–230.
- Barron TI, Connolly RM, Sharp L, et al. Beta blockers and breast cancer mortality: a population-based study. J Clin Oncol 2011;29: 2635–2644.
- Lemeshow S, Sorensen HT, Phillips G, et al. Beta-blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. Cancer Epidemiol Biomarkers Prev 2011;20:2273–2279.
- Aksu S, Beyazit Y, Haznedaroglu IC, et al. Over-expression of angiotensin-converting enzyme (CD143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML. Leuk Lymphoma 2006;47:891–896.
- Zambidis ET, Park TS, Yu W, et al. Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 2008;112:3601–3614.
- De la Iglesia Inigo S, Lopez-Jorge CE, Gomez-Casares MT, et al. Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: a new role in the treatment of leukaemia for these agents. Leuk Res 2009;33:810–816.
- Stanojkovic TP, Zizak Z, Mihailovic-Stanojevic N, et al. Inhibition of proliferation on some neoplastic cell lines-act of carvedilol and captopril. J Exp Clin Cancer Res 2005;24:387–395.
- Hajighasemi F, Mirshafiey A. In vitro sensitivity of leukemia cells to propranolol. J Clin Med Res 2009;1:144–149.
- Prevarskaya N, Skryma R, Shuba Y. Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer 2011;11:609–618.
- Wang W, Xiao J, Adachi M, et al. 4-Aminopyridine induces apoptosis of human acute myeloid leukemia cells via increasing [Ca2+]i through P2X7 receptor pathway. Cell Physiol Biochem 2011; 28:199–208.
- Wang L, Xu B, White RE, et al. Growth factor-mediated K+ channel activity associated with human myeloblastic ML-1 cell proliferation. Am J Physiol 1997;273:C1657–C1665.
- Wu ZZ, Li DP, Chen SR, et al. Aminopyridines potentiate synaptic and neuromuscular transmission by targeting the voltage-activated calcium channel beta subunit. J Biol Chem 2009;284:36453–36461.
- Abdullaev IF, Bisaillon JM, Potier M, et al. Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation. Circ Res 2008;103:1289–1299.
- Yanamandra N, Buzzeo RW, Gabriel M, et al. Tipifarnib-induced apoptosis in acute myeloid leukemia and multiple myeloma cells depends on Ca2 + influx through plasma membrane Ca2 + channels. J Pharmacol Exp Ther 2011;337:636–643.
- Bogeski I, Kilch T, Niemeyer BA. ROS and SOCE: recent advances and controversies in the regulation of STIM and Orai. J Physiol 2012;590:4193–4200.
- Huang Z, Li H, Guo F, et al. Egr-1, the potential target of calcium channel blockers in cardioprotection with ischemia/reperfusion injury in rats. Cell Physiol Biochem 2009;24:17–24.
- Stepien O, Marche P. Amlodipine inhibits thapsigargin-sensitive CA(2+) stores in thrombin-stimulated vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2000;279:H1220–H1227.
- O’Donnell MR, Abboud CN, Altman J, et al. Acute myeloid leukemia. J Natl Compr Cancer Netw 2012;10:984–1021.
- Zhou SF. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr Drug Metab 2008;9:310–322.
- Mason RP. Calcium channel blockers, apoptosis and cancer: is there a biologic relationship? J Am Coll Cardiol 1999;34:1857–1866.
- Trump BF, Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J 1995;9:219–228.
- Liang F, Schulte BA, Qu C, et al. Inhibition of the calcium- and voltage-dependent big conductance potassium channel ameliorates cisplatin-induced apoptosis in spiral ligament fibrocytes of the cochlea. Neuroscience 2005;135:263–271.
- Leszczynski D, Zhao Y, Luokkamaki M, et al. Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells. Am J Pathol 1994;145:1265–1270.
- Kondo S, Yin D, Morimura T, et al. Combination therapy with cisplatin and nifedipine inducing apoptosis in multidrug-resistant human glioblastoma cells. J Neurosurg 1995;82:469–474.